Back to search

Article

RANKL signaling sustains primary tumor growth in genetically engineered mouse models of lung adenocarcinoma

2017-05-26

Abstract excerpt

<h4>Summary</h4> <h4>Hypothesis</h4> Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality. Recent retrospective clinical analyses suggest that blocking the receptor activator of NF-κB (RANK) signaling pathway inhibits the growth of NSCLC and might represent a new treatment strategy. <h4>Methods</h4> RANK and RANKL expression in human lung adenocarcinoma was interrogated from publicly ava...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
eec23124-8502-53f2-84a8-c13cfbce78f3
DOI
10.1101/142620
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
RANKL signaling sustains primary tumor growth in genetically engineered mouse models of lung adenocarcinomaDOI 10.1101/142620
Select a neighboring publication to make it the new centre.